Universal Health Services (UHS) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
7 May, 2026Executive summary
Net revenues increased 9.6% year-over-year to $4.50 billion for Q1 2026, with strong growth in both acute care and behavioral health segments.
Net income attributable to shareholders rose 10% to $349 million ($5.65 per diluted share), with adjusted EPS up 16.1% year-over-year.
EBITDA net of NCI reached $651.7 million, up from $603.9 million year-over-year.
Announced definitive agreement to acquire Talkspace, a leading virtual behavioral health platform, for $835 million, expected to close in Q3 2026 and be accretive to earnings within 12 months post-closing.
Maintained steady operating performance and cash flow despite challenging seasonal volume trends.
Financial highlights
Operating income rose to $503 million from $455 million year-over-year.
Cash flow from operations was $402 million, up from $360 million year-over-year.
Capital expenditures totaled $217 million in Q1 2026.
Repurchased 675,000 shares for $127 million; $1.3 billion buyback authorization remains.
Debt/total capitalization improved to 38.7% from 40.7% year-over-year.
Outlook and guidance
Reiterated full-year 2026 financial and operating guidance set in February.
Expects earnings ramp through the year to achieve core 5% growth target, with volume and pricing more balanced as seasonal impacts subside.
Guidance includes $75 million pre-tax impact from health insurance exchange (HIX) declines, expected to steepen as the year progresses.
Anticipate annual net benefit from Medicaid supplemental payment programs to decline by $432–$480 million by 2032 due to legislative changes.
Management highlighted risks from changes in Medicaid and Medicare funding, new legislation affecting Medicaid eligibility, and interest rate volatility.
Latest events from Universal Health Services
- Virtual annual meeting to vote on director, pay, auditor, and ESG-related proposals.UHS
Proxy filing9 Apr 2026 - Board recommends for director elections and compensation, against both shareholder proposals.UHS
Proxy filing9 Apr 2026 - Strong 2025 growth and higher 2026 outlook, but regulatory and funding risks persist.UHS
Q4 20258 Apr 2026 - Talkspace acquisition and AI investments drive outpatient growth and operational efficiency.UHS
Barclays 28th Annual Global Healthcare Conference10 Mar 2026 - Acquisition of Talkspace boosts outpatient behavioral health and virtual care capabilities.UHS
Leerink Global Healthcare Conference 20269 Mar 2026 - 2026 guidance targets 2%-3% volume growth, with focus on staffing, outpatient, and AI initiatives.UHS
TD Cowen 46th Annual Health Care Conference3 Mar 2026 - Director elections and auditor ratification passed; annual director election proposal failed.UHS
AGM 20253 Feb 2026 - Q2 net income surged 69% and 2024 guidance was raised; $1B added to share repurchase.UHS
Q2 20242 Feb 2026 - Strong acute volumes, robust behavioral pricing, and margin recovery drive positive outlook.UHS
Goldman Sachs 45th Annual Global Healthcare Conference22 Jan 2026